Clinical Trials Browser

Prostatic Neoplasms, Castration-Resistant × niraparib × 90 days × Clear all

NCT03748641 2026-06-05

MAGNITUDE

Phase 3 Active not recruiting

765 enrolled 16 charts 1 FDA

Prostatic Neoplasms, Castration-Resistant

NCT03431350 2026-05-11

QUEST

Phase 2 Active not recruiting

136 enrolled 29 charts

Prostatic Neoplasms, Castration-Resistant